Australia's INOVIQ hits 3-1/2-month high after positive cancer study results

Inoviq

22/09/2025 04:14

** Shares of Australia's INOVIQ IIQ.AX rise as much as 22.5% to A$0.49, their highest point since June 4

** The biotechnology firm says a study conducted by the Peter MacCallum Cancer Centre confirms its technology - CAR-NK-exosomes - as potent in anti-tumour activity against triple negative breast cancer cells

** Study conducted in vitro, meaning outside living organisms

** IIQ stock logs biggest intraday pct gain since June 2

** Around 1.1 million shares change hands, 19.6x the 30-day avg volume

** YTD, stock down 22.3%

 (Reporting by Shruti Agarwal in Bengaluru)

 ((Shruti.Agarwal@thomsonreuters.com))